http://dicerna.com/wp-content/uploads/2018/02/Dicerna-Pipeline-Graphic-Feb-26-2018.jpg
Benitec [$3.20 Nasdaq] is priced at where Dicerna [$3.50] was six months ago. Dicerna recently traded at $14. SIX MONTHS LATER. Both companies have made similar pipeline progress [see link above].
Some early good data from Benitec's cancer trial reaffirming the efficacy of ddrnai will send our share price to similar levels as investors realise how close the value of Benitec's uncontested OPMD's 1 billion market is - especially with US and European regulatory authorities assisting.
Good luck to all long-term and new holders. Re-rate coming soon. Spider senses tingling [the ointment didn't work]
Add to My Watchlist
What is My Watchlist?
